TOMI Environmental Solutions Announces Partnership with Avantor Expanding Presence of SteraMist Use in Critical Controlled Environments
13 Setembro 2023 - 9:30AM
TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a
global company specializing in disinfection and decontamination
solutions, today announced expansion of their distribution channels
with Avantor® (NYSE: AVTR), a Fortune 500 company and a leading
supplier of mission-critical products and services.
This agreement represents a significant
milestone for TOMI and highlights a shared commitment to advancing
public health and safety. Our partnership is now in the
go-to-market phase to ensure a successful market penetration for
SteraMist to be a key solution for Avantor’s critical controlled
environment customers.
Avantor's vast global network and expertise in
procurement provide a significant advantage in reaching a wider
customer base, while TOMI's cutting-edge technology complements
Avantor's offerings, delivering enhanced value and ensuring optimal
cleanliness and microbial reduction to any cleanroom space. The
joint marketing efforts will pave the way for accelerated growth
for SteraMist under this strengthened collaboration.
Elissa J. (E.J.) Shane, COO of TOMI Environment
Solutions, expressed her enthusiasm about the partnership, stating,
“Joining forces with Avantor strengthens our commitment to
promoting the well-being of businesses and communities safeguarding
all critical environments. Avantor's professionalism, reputation,
and reach align perfectly with our mission and this collaboration
will play a pivotal role in expanding the use of our SteraMist
Surface Unit, SteraMist Environment System, and iHP Custom
Engineered System in cleanrooms or controlled environments
achieving unparalleled cleanliness and disinfection decontamination
levels.”
TOMI™ Environmental Solutions, Inc.:
Innovating for a safer
world® TOMI™ Environmental Solutions, Inc.
(NASDAQ: TOMZ) is a global decontamination and infection prevention
company, providing environmental solutions for disinfection through
the manufacturing, sales and licensing of its premier Binary
Ionization Technology ® (BIT™) platform. Invented under a defense
grant in association with the Defense Advanced Research Projects
Agency (DARPA) of the U.S. Department of Defense, BIT™ solution
utilizes a low percentage hydrogen peroxide as its only active
ingredient and uses patented ionized Hydrogen Peroxide (iHP™)
technology in all SteraMist systems to create superior
disinfection. TOMI products are designed to service a broad
spectrum of use sites, including, but not limited to, hospitals and
medical facilities, biosafety labs, pharmaceutical facilities,
commercial and office buildings, schools, restaurants, meat and
produce processing facilities, and police and fire
departments.
For additional information, please visit https://steramist.com/
or contact us at info@tomimist.com
Safe Harbor Statement under the Private Securities Litigation
Reform Act of 1995
This press release contains forward-looking
statements that are based on current expectations, estimates,
forecasts and projections of future performance based on
management’s judgment, beliefs, current trends, and anticipated
product performance. These forward-looking statements include,
without limitation, statements relating to our partnership with
Avantor. Forward-looking statements involve risks and uncertainties
that may cause actual results to differ materially from those
contained in the forward-looking statements. Forward-looking
statements involve a number of risks and uncertainties, all of
which are difficult or impossible to predict accurately and many of
which are beyond our control. As such, our actual results could
differ materially and adversely from those expressed in any
forward-looking statements as a result of various factors.
Important factors that could affect our performance and cause
results to differ materially from management’s expectations are
described in the section entitled “Risk Factors,” in our Annual
Report on Form 10-K and other SEC filings. These factors include:
our history of losses that may prevent us from achieving
profitability in the future; our lack of long-term customer
contracts and our inability to rely on our sales history or backlog
as an indicator of our future sales; that we are subject to a
variety or risks associated with doing business internationally;
our success in business depends on our ability to adequately
protect our intellectual property; completing of quarter-end
financial closing procedure, and that our stock price is volatile
and there is a limited market for our shares. Although we believe
that the expectations reflected in the forward-looking statements
are reasonable, we cannot guarantee future results, level of
activity, performance, or achievements. You should not place undue
reliance on these forward-looking statements. All information
provided in this press release is as of today’s date, unless
otherwise stated, and we undertake no duty to update such
information, except as required under applicable law.
INVESTOR RELATIONS CONTACT:
John Nesbett/Rosalyn Christian
IMS Investor Relations
tomi@imsinvestorrelations.com
Avantor (NYSE:AVTR)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Avantor (NYSE:AVTR)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024